Mylan Rebounds After FDA Report Signals All Clear

Today’s tickers: MYL, MU, ACAD, PAAS, PALM, KLAC, LDK, OIH & SM MYL – The global pharmaceutical manufacturer released the final findings of an FDA investigation review of its Morgantown W Va. manufacturing plant, which came under the microscope following a local newspaper’s scathing report alleging health and safety wrong doings. The FDA found nothing wrong with the operations, much to the pleasure of Mylan shareholders as new investors sent its shares higher by 3.8% to $14.12. Mylan’s valuation now stands above the point it was trading at the day prior to the story. Shares fell from $13.93 to $11.66 on the report prompting investors to seek the safety of protective puts. Investors today are taking a different take and have scooped up almost 10,000 bullish call options expiring in September granting rights to buy shares at a fixed $15 per share. The number of open positions at that strike as of Wednesday evening was 8,576 contracts. Investors paying 55 cents for calls are predicting a break to a fresh 52-week high for Mylan’s shares indicating a rally by as much as 10% within a month. Around four times the number of calls traded today compared to puts. – Mylan Inc. MU – The demand for call options on the manufacturer of flash memory products far outweighed that of calls as investor activity drove the call-to-put ratio up to more than 25-to-1. The call option feeding-frenzy was likely induced by the more than 3.5% rally in shares of MU to $7.00. About 1,000 calls were picked up at the nearer-term September 8.0 strike price for an average premium of 15 cents apiece. Bullishness spread to the October contract where traders splurged on 5,600 now at-the-money October 7.0 strike calls for an average premium of 66 cents each. Finally, traders got long of some 7,500 call options at the higher October 8.0 strike for about 40 cents per contract. A 20% increase over the current price per share by expiration, would allow investors long the October 8.0 strike calls to begin to accumulate profits above the breakeven point at $8.40. – Micron Technology, Inc. ACAD – Shares of the biopharmaceutical company have soared upwards of 17.5% during the trading session and currently stand at $6.23. ACAD appeared on our ‘hot by options volume’ market scanner after one investor initiated a long butterfly spread in the September contract. The trader constructed the butterfly by purchasing wings in the amounts of…
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.